Related Experiment Videos
Low-vision aids in Stargardt's disease.
1Department of Ophthalmology, Faculty of Medicine, University of Marmara, Istanbul, Turkey.
Summary
Low-vision aids (LVAs) effectively improved visual acuity in Stargardt
Area of Science:
- Ophthalmology
- Low Vision Rehabilitation
- Genetics
Background:
- Stargardt disease is a common inherited macular dystrophy causing progressive vision loss.
- Many patients retain some distance vision but experience significant near vision impairment.
- Low-vision aids (LVAs) are optical or electronic devices designed to enhance remaining vision.
Purpose of the Study:
- To evaluate the effectiveness of low-vision aids (LVAs) in improving distance and near visual acuity.
- To determine the success rate of prescribing near visual aids for patients with Stargardt disease.
- To identify factors contributing to successful LVA use in this population.
Main Methods:
- A prospective study involving 27 patients diagnosed with Stargardt disease.
- Assessment of distance and near visual acuity with and without corrective lenses.
- Prescription and evaluation of appropriate low-vision aids, focusing on near tasks.
- Analysis of patient demographics, motivation, and refractive error in relation to LVA success.
Main Results:
- Most patients possessed usable distance vision, with or without glasses.
- A high success rate of 89% (24 out of 27 patients) was achieved in prescribing near visual aids.
- Successful outcomes were associated with younger age, high motivation, and myopic refractive errors.
Conclusions:
- Low-vision aids (LVAs) demonstrate significant efficacy in enhancing near visual acuity for individuals with Stargardt disease.
- The study recommends considering LVAs for patients with Stargardt disease experiencing visual challenges.
- Patient-specific factors such as age, motivation, and refractive error play a crucial role in the success of low-vision aid interventions.